CRISPR Therapeutics CRSP
CRISPR Therapeutics: reports an executive or board change, amends its charter or bylaws and reports shareholder vote results
- Form
- 8-K
- Filed
- Importance
- Routine
- Accession
- 0001193125-26-257593
- Reports an executive or board change (5.02)
- Amends its charter or bylaws (5.03)
- Reports shareholder vote results (5.07)
Not explained yet; the original is on EDGAR.
Similar companies
Companies of similar size in SIC 2836 and related industry codes: the same peer list as the financial tables.
- Soleno Therapeutics SLNO public float $4.1B, Jun 30, 2025
- Adma Biologics ADMA public float $4.2B, Jun 30, 2025
- Lantheus Holdings LNTH public float $4.3B, Jun 30, 2025
- Merus MRUS
- Axsome Therapeutics AXSM public float $4.4B, Jun 30, 2025
